Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Initial immunologic evaluations in breast and thyroid cancer]

S Abeatici, A Mussa, P Levis

    Minerva Medica
    |April 28, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients.

    Frontiers in pediatrics·2024
    Same author

    False-negative real-time polymerase chain reaction tests in COVID-19 patients: an epidemiological analysis of 302 patients.

    Public health·2021
    Same author

    Rhizospheric bacterial isolates of grass pea (Lathyrus sativus L.) endowed with multiple plant growth promoting traits.

    Journal of applied microbiology·2018
    Same author

    Solitary pancreatic head metastasis from tibial adamantinoma: a rare indication to pancreaticoduodenectomy.

    Journal of surgical case reports·2018
    Same author

    Centers of excellence or excellence networks: The surgical challenge and quality issues in rare cancers.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
    Same author

    Perioperative nutrition in cancer patients.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
    Same journal

    Smoking, healthy lifestyle and adolescence.

    Minerva medica·2026
    Same journal

    How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

    Minerva medica·2026
    Same journal

    Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

    Minerva medica·2026
    Same journal

    Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

    Minerva medica·2026
    Same journal

    Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

    Minerva medica·2026
    Same journal

    Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

    Minerva medica·2026
    See all related articles

    This study evaluated immune status in tumor patients. Carcinoembryonic antigen (CEA) levels decreased post-surgery, suggesting a link to prognosis in malignancy.

    Area of Science:

    • Oncology
    • Immunology
    • Surgical Oncology

    Context:

    • Assessing immunological status in patients with breast and thyroid tumors (malignant and benign).
    • Evaluating pre- and post-operative immune markers to understand patient response to treatment.

    Purpose:

    • To evaluate the pre- and post-operative immunological status of patients with malignant and benign breast and thyroid lesions.
    • To identify potential immune markers correlating with tumor prognosis and surgical outcomes.

    Summary:

    • Immune markers including rosette E test, CEA, cortisol, immunocomplexes, leukocytes, B lymphocytes, and immunoglobulins were analyzed in 15 malignant and 9 benign tumor patients.
    • No significant lack of immune response was observed in tumor-bearing patients.
    • Carcinoembryonic antigen (CEA) emerged as a potentially significant prognostic marker, with high serum levels in malignancies tending to decrease after surgical intervention.

    Related Experiment Videos

    Impact:

    • Highlights CEA as a potential biomarker for monitoring malignancy progression and treatment response.
    • Provides insights into the immunological profile of patients undergoing surgery for breast and thyroid tumors.
    • Suggests further research into CEA's role in predicting outcomes for cancer patients.